Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

14 Aug 2009 07:00

RNS Number : 4266X
Creston PLC
14 August 2009
 



Press Release  14 August 2009

Creston plc 

Interim Management Statement 

Creston plc (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 April 2009 to 30 July 2009.

Trading

The Group's trading overall remains in line with management's expectations. After a robust performance in our last financial year, which saw like-for-like revenue growth in each quarter and 4 per cent for the full year, the prevailing economic recession has caused an anticipated decline and re-phasing of marketing budgets for some clients during the first quarter of the new financial year. The Group has reported a like-for-like revenue decline of 6 per cent for the first quarter compared with the particularly strong first quarter growth of 5 per cent last year. 

The Insight Division had its highest level of secured commissions by this point in the year. The Communications Division has been effected by the expected client budget cuts, however, this has been partly offset by the new business wins from last year. The Health Division's growth has been driven by the new medical education and international offers and their continuing excellent performance in new business.

Although the current economic climate is having an effect on client budgets, we continue to win new business to offset the impact. New business wins to date include Astellas, Astra Zeneca, BMW Motorrad, COI (blood and transplant and vulnerable workers), E-on, GSK and Saudi Arabian General Investment Authority plus other major wins yet to be announced. The new business pipeline remains strong and with a historical high pitch to win ratio, we are confident of winning a good proportion of the opportunities. 

Balance Sheet

On 7 July 2009 the Company successfully raised £3.3m (gross) through a limited capital raising from long term shareholders. The fundraising provides additional working capital for the Group, and also allows for investment in our organic growth plans in areas such as mobile and digital healthcare marketing.

The Group continues to manage its working capital effectively and has generated operating cash flow in line with the Board's expectations. 

Outlook

Despite the current economic climate we believe that the Group's new divisional structure and the new business pipeline stand the Group in good stead for the full year. 

For further information, please contact:

Creston plc

020 7930 9757

Don Elgie, Chief Executive

Barrie Brien, COO/CFO

www.creston.com 

Hogarth Partnership Limited

020 7357 9477

Chris Matthews/Fiona Noblet/Anthony Arthur

 

About Creston plc

Creston is an Insight and Communications company for the 21st century. It offers clients more seamless access to the most innovative marketing insights and communications services to help grow their brands in a rapidly-changing consumer world. Our companies draw upon the collective knowledge, expertise and services from across-the-Group, so that their clients receive the best advice and achieve the best results no matter what the medium. By working together, whether on research or as full-scale marketing partners, our companies continuously innovate to make more things possible for their clients and people.

Creston companies offer a range of marketing services, such as advertising, direct and digital marketing, market research, public relations and healthcare marketing to a broad range of blue-chip clients including: Amazon, AstraZeneca, Aviva, Bayer, BMW, BT, Burger King, Canon, COI Communications, Cow & Gate, Daily Mirror, Diageo, E-on, First Direct, GlaxoSmithKline, Halifax, Homeform, House of Fraser, Kimberly-Clark, Lexus, Lloyds Black Horse, Morrisons, NHS Lottery, Nissan, Opel, Pfizer, Roche Diagnostics, Royal Mail, SAB Miller, Sainsbury's, Tesco, Thorpe Park, Toshiba, Trinity Mirror, T-Mobile, Tropicana, Unilever, Vauxhall, Vodafone, Walkers and WH Smith.

Creston's share price is quoted in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAKPDFEXNEFE
Date   Source Headline
22nd Jul 20244:51 pmRNSNotice of Results
12th Jul 20246:21 pmRNSHolding(s) in Company
24th Jun 20247:00 amRNSDirector/PDMR Shareholding
24th Jun 20247:00 amRNSDirector/PDMR Shareholding
12th Jun 202412:48 pmRNSHolding(s) in Company
30th May 20247:00 amRNSHolding(s) in Company
28th May 20247:00 amRNSDirector/PDMR Shareholding
23rd May 20243:26 pmRNSDirector/PDMR Shareholding
23rd May 20247:00 amRNSHolding(s) in Company
23rd May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
22nd May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
17th May 20244:21 pmRNSDirector/PDMR Shareholding
16th May 20247:00 amRNSResult of AGM
15th May 20247:00 amRNSQ1 Trading Update
15th May 20247:00 amRNSDirectorate Change
3rd May 20244:00 pmRNSNotice of Results
30th Apr 20247:00 amRNSHolding(s) in Company
25th Apr 20244:11 pmRNSHolding(s) in Company
19th Apr 20247:00 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSNotice of AGM
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
4th Apr 20243:52 pmRNSDirector/PDMR Shareholding
28th Mar 20243:53 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
12th Mar 20243:11 pmRNSHolding(s) in Company
7th Mar 20245:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20243:53 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 20244:48 pmRNSPurchase of Shares by Employee Benefit Trust
4th Mar 20243:58 pmRNSPurchase of Shares by Employee Benefit Trust
1st Mar 20244:00 pmRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20241:40 pmRNSAnnual Financial Report
28th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20247:00 amRNSHolding(s) in Company
26th Feb 20245:44 pmRNSPurchase of Shares by Employee Benefit Trust
26th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st Feb 20247:00 amRNSAppointment of Senior Independent Director
21st Feb 20247:00 amRNSPreliminary results for the year ended 31/12/2023
13th Feb 20247:00 amRNSNotice of Full Year 2023 Trading Update
29th Jan 20247:00 amRNSPerformance Update
25th Jan 20247:00 amRNSJanuary 2024 Trading Update
15th Jan 20247:00 amRNSNotice of 1 January 2024 Renewals Trading Update
14th Dec 20235:39 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.